Water Island Capital’s Avidity Biosciences RNAM Stock Holding History
Bought
Maintained
Sold
Other funds holding RNAM
Water Island Capital's RNAM Position: Q1 2026 in Review
Water Island Capital sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 168,385 shares — an estimated $12.1M sold.
Water Island Capital first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $12.1M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.
- Water Island Capital reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
- Water Island Capital sold 168,385 Avidity Biosciences shares in Q1 2026, an estimated $12.1M.
- Water Island Capital first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
- Water Island Capital's Avidity Biosciences position peaked at $12.1M in Q4 2025.
- 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.
Based on Water Island Capital's 13F filing for Q1 2026, filed 15 May 2026.